Chronic Kidney Disease Market Industry Forecast Reflecting Growth To $101.86 Billion By 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Forecasted Market Size Figures For The Chronic Kidney Disease Market In 2026 And 2030?

The chronic kidney disease market size has demonstrated strong growth in recent years. Its valuation is projected to rise from $74.87 billion in 2025 to $79.43 billion in 2026, expanding at a compound annual growth rate (CAGR) of 6.1%. This historic growth can be ascribed to several factors, including the increasing prevalence of diabetes and hypertension, enhanced availability of dialysis infrastructure, advancements in kidney function diagnostics, a rising awareness of chronic renal disorders, and the expansion of nephrology care services.

The chronic kidney disease market size is projected to experience significant expansion in the coming years, with an anticipated growth to $101.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected growth throughout the forecast period can be attributed to several factors, including the increasing development of innovative renal therapies, a rising demand for patient-centric dialysis alternatives, the expansion of digital kidney health monitoring systems, a growing emphasis on transplant preparedness, and increased investments in preventive nephrology. Furthermore, significant trends expected during this forecast period include a heightened focus on early detection of CKD, the increasing adoption of renoprotective drug treatments, a growing utilization of home dialysis solutions, the broadening of multidisciplinary care models, and an intensified effort to slow down the progression of the disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

What Core Drivers Are Transforming The Chronic Kidney Disease Market?

The growing incidence of kidney disease is anticipated to propel the chronic kidney disease market forward. Kidney diseases are a group of conditions that affect the kidneys’ structure and function. Medications for kidney disease are administered to patients to control blood pressure and reduce protein loss, aiming to halt the advancement of kidney impairment, alleviate symptoms, and prevent further consequences. For example, in June 2023, Kidney Research UK, a charity in the UK dedicated to funding kidney disease research, projected that by 2033, the population affected by CKD stages 3–5 will likely increase to around 3.9 million. This increasing prevalence of kidney disease is therefore a significant driver of growth for the chronic kidney disease market.

What Segment Categories Are Evaluated In The Chronic Kidney Disease Market Study?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-Ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Which Trends Are Shaping The Chronic Kidney Disease Market Landscape?

Leading companies operating within the chronic kidney disease market are increasingly adopting strategic partnership approaches to investigate the safety and efficacy of an enhanced Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Strategic partnerships are defined as a process where organizations combine their respective strengths and resources to achieve mutual benefits and success. As an illustration, in June 2023, AWAK Technologies Pte Ltd., a medical technology company based in Singapore, formed a partnership with Singapore General Hospital Pte Ltd. (SGH), an academic health science center and hospital also located in Singapore. The aim of this collaboration is to revolutionize the diagnosis, treatment, and management of kidney disease, encompassing the development and testing of a wearable and ultra-portable peritoneal dialysis (PD) system, known as AWAK PD, which will allow patients suffering from end-stage kidney disease to undergo dialysis conveniently at home and while on the move.

Which Organizations Are Operating Within The Chronic Kidney Disease Market?

Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Access The Complete Chronic Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Region Has The Strongest Presence In The Chronic Kidney Disease Market?

North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Chronic Kidney Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Browse Through More Reports Similar to the Global Chronic Kidney Disease Market 2026, By The Business Research Company

Peripheral Neuropathy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report

Optic Nerve Disorders Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795